This article provides an assessment of nitrosamine contamination specifically in biologics and contrasts the potential risks between these product types.

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Are Nitrosamines a Concern for Biologic Manufacturers

Newsletter